A late-stage study has shown promising results for the effectiveness of fenfluramine in people with an ultra-rare form of epilepsy - CDKL5 deficiency disorder (CDD).

Deborah Bourne joined the Epilepsy Society as Fundraising and Marketing Director in December 2024 and will be working with us until December 2025. Deborah will be leading our fundraising activities ...

Campaigns Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from ...

It is always your choice as to whether you want to receive information from us. You may opt-out of our marketing communications by clicking the ‘unsubscribe’ link at the end of our marketing emails or ...

Sodium valproate is an epilepsy medication prescribed for all seizure types including absence, myoclonus and tonic clonic seizures. New regulations have been introduced by the Medicines and Healthcare ...

Read the latest updates on epilepsy medication, including medication shortages. Always try to get your prescription to your pharmacy in good time – up to seven days before you need it. This will ...

Our ‘Epilepsy care - your rights’ information explains your rights and choices with regard to your epilepsy care and treatment. You also have responsibilities. ‘Rights’ are in the NHS Constitution and ...

Two important laws that apply to employment are the Health and Safety at Work Act 1974 and the Equality Act 2010. Health and safety law The Health and Safety at Work Act 1974 says that employers are ...

Sodium valproate can cause serious problems in a developing baby. The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued regulations on the way it is prescribed to both men and ...